This inventor holds 1 USPTO granted patent. Top assignee: Cheil Foods & Chemicals, Inc.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Innovations of Hyune W Lee in Human Proinsulin Production.
Introduction
Hyune W Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of human proinsulin. His innovative approach utilizes gene manipulation technology to enhance the yield of proinsulin, which is crucial for diabetes treatment.
Latest Patents
Hyune W Lee holds a patent for the "Production of human proinsulin using a novel vector system." This patent describes a process for producing human proinsulin in Escherichia coli (E. coli) through a novel expression vector. The vector incorporates strong regulatory elements of an insulin gene and a stable recombinant gene product. The key features of this expression vector include an 11 amino acid leader peptide for intracellular stability, two copies of a DNA expression cassette with a strong lambda P.sub.R promoter, and an ampicillin resistance gene. This innovative system allows for high yields of human proinsulin, which can be converted into insulin through in vitro processes.
Career Highlights
Hyune W Lee is currently employed at Cheil Foods & Chemicals, Inc., where he continues to advance his research in biotechnology. His work has positioned him as a key figure in the development of efficient methods for insulin production.
Collaborations
Hyune W Lee collaborates with esteemed colleagues such as Ji W Yoon and Yup Kang. Their combined expertise contributes to the ongoing advancements in the field of biotechnology.
Conclusion
Hyune W Lee's innovative work in the production of human proinsulin showcases the potential of biotechnology to improve healthcare solutions. His contributions are vital for the advancement of diabetes treatment and highlight the importance of research in this field.